Chitosan-based Hemostasis Management Products Market Report 2026

Chitosan-based Hemostasis Management Products Market Overview

• Chitosan-based Hemostasis Management Products market size has reached to $1.65 billion in 2025 • Expected to grow to $2.64 billion in 2030 at a compound annual growth rate (CAGR) of 9.8% • Growth Driver: The Rise In Traumatic Injuries Driving The Growth Of The Market Due To Increasing Road Accidents And Effective Blood Clotting Solutions • Market Trend: Breakthrough Hemostatic Spray Set To Transform Emergency Bleeding Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Chitosan-based Hemostasis Management Products Market?

Chitosan-based hemostasis management products are medical devices or materials that use chitosan, a natural biopolymer derived from chitin, to rapidly stop bleeding by promoting blood clotting and platelet aggregation at the wound site. These products are commonly used in surgical, emergency, and trauma care settings as an effective alternative or adjunct to traditional hemostatic methods such as gauze or pressure dressings. The main product types of chitosan-based hemostasis management products include dressings, sponges, powders, and other product type. Dressings refer to chitosan-infused materials designed to promote rapid blood clotting and control bleeding in surgical or traumatic settings. They find application in surgical wounds, trauma, and other application, serving end users including hospitals, ambulatory surgical centers, and other application.

What Is The Chitosan-based Hemostasis Management Products Market Growth Forecast?

The chitosan-based hemostasis management products market size is expected to see strong growth in the next few years. It will grow to $2.64 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to growing adoption of advanced hemostatic powders, rising demand for minimally invasive surgical solutions, increasing use in emergency and trauma care, expansion of product offerings in ambulatory surgical centers, growing focus on antimicrobial and biocompatible hemostatic solutions. Major trends in the forecast period include increasing adoption of chitosan-based hemostatic dressings, rising demand for absorbable hemostatic sponges, growing integration of sprayable and topical hemostatic powders, expansion of hemostatic sealants and bandages in trauma care, rising focus on antimicrobial and adhesive hemostatic products.

Global Chitosan-based Hemostasis Management Products Market Segmentation

1) By Product Type: Dressings, Sponges, Powders, Other Product Types 2) By Application: Surgical Wounds, Trauma, Other Applications 3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users Subsegments: 1) By Dressings: Hemostatic Gauze Dressings, Adhesive Hemostatic Dressings, Compression Dressings, Antimicrobial Dressings 2) By Sponges: Absorbable Hemostatic Sponges, Surgical Hemostatic Sponges, Nasal Hemostatic Sponges, Dental Hemostatic Sponges 3) By Powders: Topical Hemostatic Powders, Sprayable Hemostatic Powders, Surgical Hemostatic Powders, Veterinary Hemostatic Powders 4) By Other Product Types: Hemostatic Bandages, Hemostatic Sealants, Hemostatic Films, Hemostatic Tampons

What Are The Drivers Of The Chitosan-based Hemostasis Management Products Market?

The increasing prevalence of traumatic injuries is expected to propel the growth of the chitosan-based hemostasis management products market going forward. Traumatic injuries refer to physical harm or damage to the body caused by sudden external forces, such as accidents, falls, or violence, which can affect tissues, organs, bones, or the nervous system. The increasing prevalence of traumatic injuries is due to road traffic accidents, which account for a significant proportion of severe injuries worldwide because of high vehicle density, speeding, and inadequate road safety measures. Chitosan-based hemostasis management products help traumatic injuries by rapidly promoting blood clotting at the wound site, reducing blood loss, and supporting faster stabilization compared to traditional gauze or pressure-only methods. For instance, in October 2024, according to the Department of Health Alaska, a US-based government department, in 2023, approximately 3,373 individuals in Alaska experienced traumatic brain injuries (TBI). Therefore, the increasing prevalence of traumatic injuries is driving the growth of the chitosan-based hemostasis management products industry. The increasing number of surgical procedures is expected to propel the growth of the chitosan-based hemostasis management products market going forward. Surgical procedures refer to medically performed operations involving incisions, manipulations, or removal of tissues to diagnose, treat, or repair injuries, diseases, or deformities. The increasing number of surgical procedures is mainly driven by the growing prevalence of chronic diseases, as more patients require operative interventions to manage or treat long-term health conditions. Chitosan-based hemostasis management products help surgical procedures by rapidly promoting blood clot formation at the site of bleeding, thereby reducing blood loss, shortening operative time, and improving overall surgical outcomes. For instance, according to the 2024 annual report by Intuitive Surgical Inc., a US-based medical device company, around 2,683,000 surgical procedures were carried out using da Vinci surgical systems, up from approximately 2,286,000 procedures in 2023 and 1,875,000 procedures in 2022, reflecting steady year-over-year growth in utilization. Therefore, the increasing number of surgical procedures is driving the growth of the chitosan-based hemostasis management products industry.

Key Players In The Global Chitosan-based Hemostasis Management Products Market

Major companies operating in the chitosan-based hemostasis management products market are BenQ Materials Corporation, Core Scientific Creations Ltd, Advanced Medical Solutions Group plc, Ore-Medix LLC, Axio Biosolutions Pvt. Ltd., Marine Polymer Technologies Inc., Tri‑Tech Forensics Inc, The Seaberg Company Inc, Tricol Biomedical Inc., Datsing Bio-Tech Co Ltd., Medtrade Products Ltd., Gelita Medical GmbH, HemCon Medical Technologies Inc, Hemostasis LLC, BC3 Technologies Inc, Omni-stat Medical Inc, MMC MedTech Co Ltd, Anhui Wound Solutions, ChitoTech Company, CoreLeader Biotech Co. Ltd.

Global Chitosan-based Hemostasis Management Products Market Trends and Insights

Major companies operating in the chitosan-based hemostasis management products market are focusing on developing innovative products, such as aerosolized chitosan hemostatic sprays, to rapidly control bleeding and improve emergency trauma care. An aerosolized chitosan hemostatic spray is a medical product that delivers chitosan in a fine mist to a wound, forming a quick acting barrier that helps stop bleeding. For instance, in April 2023, BC3 Technologies Inc., a US-based medical device company, received approval from the U.S. Food and Drug Administration (FDA) for BC3’s SEAL Hemostatic Wound Spray, an aerosolized chitosan hemostatic spray designed to rapidly control bleeding. The spray forms a physical barrier on wounds, promoting clot formation and enabling quick management of serious arterial and traumatic bleeding. Following clearance, the product became available for use by first responders, military personnel, and emergency medical services, enhancing on-site hemorrhage control capabilities. This approval also positions BC3 Technologies to expand its presence in the trauma care and emergency medical device market.

Regional Insights

North America was the largest region in the chitosan-based hemostasis management products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Chitosan-based Hemostasis Management Products Market?

The chitosan-based hemostasis management products market consists of sales of chitohem powder, chitosponge, hemogauze hemostatic band aid, chitocell ultra‑thin pads, and chitoclot gauze. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Chitosan-based Hemostasis Management Products Market Report 2026?

The chitosan-based hemostasis management products market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chitosan-based hemostasis management products industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.